Ascendis Pharma AS (ASND)
124.04
-0.34
(-0.27%)
USD |
NASDAQ |
Nov 21, 14:19
Ascendis Pharma Price: 124.04 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 124.44 | 125.52 | 122.30 | 124.38 | 304170.0 |
| Nov 19, 2024 | 120.11 | 125.06 | 119.08 | 124.44 | 714101.0 |
| Nov 18, 2024 | 127.34 | 127.34 | 120.73 | 122.00 | 611083.0 |
| Nov 15, 2024 | 118.98 | 133.00 | 118.05 | 126.51 | 1.449M |
| Nov 14, 2024 | 126.10 | 127.56 | 124.20 | 124.28 | 975223.0 |
| Nov 13, 2024 | 128.50 | 129.86 | 125.15 | 126.03 | 594030.0 |
| Nov 12, 2024 | 127.39 | 129.51 | 125.40 | 127.67 | 417745.0 |
| Nov 11, 2024 | 124.83 | 129.81 | 124.45 | 128.40 | 301243.0 |
| Nov 08, 2024 | 127.40 | 128.20 | 124.11 | 124.33 | 459304.0 |
| Nov 07, 2024 | 129.28 | 129.28 | 126.26 | 126.55 | 266595.0 |
| Nov 06, 2024 | 130.50 | 132.46 | 126.71 | 129.36 | 445441.0 |
| Nov 05, 2024 | 124.52 | 129.31 | 122.13 | 128.13 | 282035.0 |
| Nov 04, 2024 | 127.20 | 129.17 | 123.03 | 125.77 | 486116.0 |
| Nov 01, 2024 | 124.04 | 125.94 | 121.51 | 125.28 | 389318.0 |
| Oct 31, 2024 | 121.40 | 124.66 | 120.77 | 122.82 | 344925.0 |
| Oct 30, 2024 | 124.92 | 126.81 | 122.50 | 122.80 | 379144.0 |
| Oct 29, 2024 | 129.56 | 129.69 | 124.02 | 126.77 | 317443.0 |
| Oct 28, 2024 | 131.25 | 133.97 | 129.14 | 129.44 | 248981.0 |
| Oct 25, 2024 | 129.93 | 131.42 | 129.17 | 130.32 | 176662.0 |
| Oct 24, 2024 | 128.00 | 130.79 | 128.00 | 129.81 | 205811.0 |
| Oct 23, 2024 | 128.73 | 130.05 | 126.44 | 127.69 | 286080.0 |
| Oct 22, 2024 | 127.36 | 129.95 | 126.02 | 129.07 | 150588.0 |
| Oct 21, 2024 | 130.44 | 130.66 | 125.58 | 128.66 | 271597.0 |
| Oct 18, 2024 | 127.70 | 131.89 | 126.59 | 129.90 | 381556.0 |
| Oct 17, 2024 | 129.52 | 130.00 | 126.00 | 126.66 | 464807.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
69.96
Minimum
Apr 28 2023
182.76
Maximum
Dec 14 2020
125.16
Average
127.12
Median
Dec 26 2023
Price Benchmarks
| Novo Nordisk AS | 102.90 |
| Evaxion Biotech AS | 1.31 |
| Trinity Biotech PLC | 1.28 |
| Biodexa Pharmaceuticals PLC | 4.43 |
| NuCana PLC | 1.28 |
Price Related Metrics
| PS Ratio | 19.96 |
| Earnings Yield | -6.53% |
| Market Cap | 7.413B |